FDA Approved: EZETIMIBE AND SIMVASTATIN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's Supplemental Application for the fixed-dose combination ezetimibe and simvastatin (EZETIMIBE AND SIMVASTATIN).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• EZETIMIBE AND SIMVASTATIN (ezetimibe and simvastatin)

Snippet

SUPPL AP for EZETIMIBE AND SIMVASTATIN (EZETIMIBE AND SIMVASTATIN)